Effectiveness and safety of antithrombotic strategies in elderly patients with acute myocardial infarction

Table 1 Baseline patients’ characteristics, n (%)

Parameters	All (n = 105)	Pathology		P value
		STEMI (n = 37)	NSTEMI (n = 68)
Age (yr)	83.9 ± 3.6	83.6 ± 3.9	84.0 ± 3.5	0.592
Males	55 (52.3)	16 (43.2)	39 (57.3)	0.239
BMI (kg/m2)	25.9 ± 5.4	25.7 ± 3.8	26 ± 6.1	0.787
LVEF (%)	45 ± 11.1	43 ± 12.2	46 ± 10.5	0.190
History of AF	15 (14.3)	5 (13.5)	10 (14.7)	0.900
Paroxysmal	7 (7.7)	3 (8.1)	4 (5.9)	-
Persistent/Permanent	8 (7.6)	2 (5.4)	6 (8.8)	-
New onset AF	10 (9.5)	3 (8.1)	7 (10.2)	0.999
Hypertension	75 (71.4)	23 (62.2)	52 (76.5)	0.186
Dyslipidemia	36 (34.3)	10 (27)	26 (38.2)	0.347
Diabetes	34 (32.4)	13 (35.1)	21 (30.9)	0.821
Overweight	20 (19)	5 (13.5)	15 (22.1)	0.421
Smoking active or previous	21 (20)	5 (13.5)	16 (23.5)	0.332
Family history of CAD	9 (8.6)	4 (10.8)	5 (7.4)	0.789
Creatinine at admission (mg/dL)	1.15 ± 0.4	1.0 ± 0.4	1.2 ± 0.5	0.039
Creatinine at discharge (mg/dL)	1.31 ± 0.6	1.3 ± 0.5	1.3 ± 0.7	0.999
Hemoglobin at admission (g/dL)	12.6 ± 2.1	13.2 ± 2.0	12.3 ± 2.1	0.035
Hemoglobin at discharge (g/dL)	12.3 ± 1.9	12.4 ± 1.7	12.2 ± 1.9	0.594

Continuous variables are presented as mean value SD or median value (IQR). STEMI: ST-elevation myocardial infarction; NSTEMI: Non-ST-elevation myocardial infarction; BMI: Body mass index; LVEF: Left ventricular ejection fraction; AF: Atrial fibrillation; CAD: Coronary artery disease.